Journal of the American Pharmacists Association

Papers
(The H4-Index of Journal of the American Pharmacists Association is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Access to community pharmacies: A nationwide geographic information systems cross-sectional analysis128
COVID-19 and influenza vaccine hesitancy among college students59
The impact of the COVID-19 pandemic on medical conditions and medication adherence in people with chronic diseases52
Prevalence and risk factors of burnout in community pharmacists47
Essential services: Quantifying the contributions of America’s pharmacists in COVID-19 clinical interventions40
The impact of pharmacist involvement on immunization uptake and other outcomes: An updated systematic review and meta-analysis38
Polypharmacy among COVID-19 patients: A systematic review37
The pharmacist’s active role in combating COVID-19 medication misinformation37
Expanded roles of community pharmacists in COVID-19: A scoping literature review33
Managing medication supply chains: Lessons learned from Taiwan during the COVID-19 pandemic and preparedness planning for the future33
The burden of COVID-19 on pharmacists32
Clinician burnout during the COVID-19 pandemic before vaccine administration29
Systemic racism: Pharmacists’ role and responsibility27
Framework to enable pharmacist access to health care data using Blockchain technology and artificial intelligence26
Reimbursement for pharmacist-provided health care services: A multistate review25
Screening for social determinants of health in community pharmacy: Identifying best practices, barriers, and strategies for success24
Addressing social determinants of health in community pharmacy: Innovative opportunities and practice models24
Counterfeit drugs: A major issue for vulnerable citizens throughout the world and in the United States23
The patterns and determinants of telemedicine use during the COVID-19 crisis: A nationwide study23
Access to pharmacies and pharmacy services in New York City, Los Angeles, Chicago, and Houston, 2015-202020
Assessing pharmacy-based naloxone access using an innovative purchase trial methodology20
Trends in glucagon-like peptide 1 receptor agonist use, 2014 to 202220
0.045445919036865